TU Delft researchers have developed a new method for producing nanocarriers loaded with radioactive salts for imaging and treatment. Because the assembly of these nanocarriers is so simple, the innovation is ideal for clinical research and cancer treatment.The findings of the research were published in the journal 'Advanced Therapeutics'.Chemotherapy is a treatment meant to attack metastasised tumours, but this method unfortunately has many adverse side effects. Nano carriers made out of so-called polymer micelles are a promising, less toxic alternative to chemotherapeutic drugs. Micelles are tiny spheres that can carry around substances inside their core."Clinicians are finding more and more applications of polymer micelles already, mostly to carry chemotherapeutic drugs," co-author of the article and Associate Professor in Applied Radiation & Isotopes Antonia Denkova explained. "Their biggest advantage is that the toxicity to healthy tissue is reduced, meaning that you could ..
Pharma firms and start-ups working to launch it within 2 yrs
The Parliamentary Committee on Health and Family Welfare will meet on Monday evening to discuss 'Affordability of Cancer Treatment' with Union Health Secretary Rajesh Bhushan
The HTL-001 peptide used in the study has undergone safety testing and is suitable for patient trials. These trials are now being considered in GBM and other cancers
Her visit to St Jude is part of her and President Joe Biden's so-called Cancer Moonshot effort, which aims to reduce the cancer death rate by at least 50% over the next 25 years
A study says, hydroxychloroquine inhibits pathways that drive resistance to chemotherapy agent cisplatin in head and neck cancers and restores tumour-killing effects of cisplatin in animal models
One of the tallest figures in the country in cancer treatment, Nair passed away on Thursday
The drug firm said it has entered into a definitive agreement with Citius to sell all of its rights to E7777 and certain related assets.
The technology minimises damage to healthy tissue by delivering high-precision radiation to tumour region which moves with respiration
India spent approximately Rs 2,386 crore in 2020 on oral cancer treatment, paid for by insurance schemes, government and private sector, spending out of pocket, donations or combination of both.
AstraZeneca Pharma India on Wednesday said it has received marketing approval from the Drugs Controller General of India (DCGI)for its product for the treatment of non-small cell lung cancer.
The product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration (USFDA)
As it takes away the legal overhang, Cipla can launch the drug once its ANDA is approved
The seven northeastern states of Assam, Meghalaya, Tripura, Arunachal Pradesh, Mizoram, Manipur and Nagaland report a higher cancer burden than the Indian average
Natco Pharma said its marketing partner Breckenridge Pharmaceutical received final approval from the USFDA for Pomalidomide Capsules, treatment of patients suffering from multiple myeloma cancer
Cancer treatment has taken a hit due to Covid, with several experts flagging an increase in risk of cancer spreading to advanced stages as almost 50% cases are reaching hospitals in later phases
The generic version of the drug has been launched under the brand name ''Bdfoie'' in the country
Drug firm Zydus Cadila said it has received final nod from USFDA to market its generic Doxorubicin Hydrochloride Liposome injection, used for treatment of certain types of cancer, in the US
The company has already set up one such facility at Chennai at an investment of around Rs 1,300 crore, and may be looking at roping investors to fund future projects
Equity infusion peged at Rs 350 crore; total capex of Rs 1,000 crore; entire business to be transferred to SPV